NCT00175240 Enhancing the Secondary Prevention of Coronary Artery Disease Status COMPLETED Phase PHASE4
NCT00174512 A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic Blockade Status COMPLETED Phase PHASE1
NCT00174486 Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction Status COMPLETED Phase PHASE2
NCT00174473 A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children Status COMPLETED Phase PHASE1/PHASE2
NCT00174460 Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age Status COMPLETED Phase PHASE2
NCT00174434 Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT00174421 Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height Status COMPLETED Phase PHASE3
NCT00174408 Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age Status COMPLETED Phase PHASE3
NCT00174382 Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia Status TERMINATED Phase PHASE3
NCT00174369 MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00174356 PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients Status COMPLETED Phase PHASE1
NCT00174343 Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients Status COMPLETED Phase PHASE2
NCT00174317 Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip Status COMPLETED Phase PHASE4
NCT00174291 Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy Status TERMINATED Phase PHASE3
NCT00174278 Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary Status COMPLETED Phase PHASE3
NCT00174252 Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age Status COMPLETED Phase PHASE3
NCT00174239 Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease. Status TERMINATED Phase PHASE4
NCT00174226 Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar Status COMPLETED Phase PHASE2